List of insiders holdings for ArriVent BioPharma Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
| 1 | HILLHOUSE INVESTMENT MANAGEMENT LTD. HHLR ADVISORS LTD. 10% Owner |
2024-11-14 16:33:47 | 4,484,672 0 |
4,484,672 | Form 13G |
| 2 | ORBIMED ADVISORS LLC OrbiMed Capital GP VIII LLC OrbiMed Advisors IV Ltd OrbiMed Asia GP IV L.P. Director 10% Owner |
2024-02-05 16:42:18 | 3,027,328 0 |
3,027,328 | Form 13D |
| 3 | HEALY JAMES Director |
2024-01-31 16:10:47 | 0 1,696,752 |
1,696,752 | Form 4 |
| 4 | GORDON CARL L Director 10% Owner |
2024-01-31 16:11:43 | 0 1,513,664 |
1,513,664 | Form 4 |
| 5 | Yao Zhengbin President and CEO |
2025-02-14 16:27:36 | 380,000 0 |
380,000 | Form 4 |
| 6 | Kung Winston Chief Financial Officer |
2025-02-14 16:24:52 | 120,000 0 |
120,000 | Form 4 |
| 7 | LaChapelle Robin Chief Operating Officer |
2025-02-14 16:25:46 | 120,000 0 |
120,000 | Form 4 |
| 8 | Lutzker Stuart President of R&D |
2025-02-14 16:26:40 | 120,000 0 |
120,000 | Form 4 |
| 9 | Kastenmayer James Paul General Counsel |
2025-02-14 16:23:58 | 102,000 0 |
102,000 | Form 4 |
| 10 | Hohneker John Director |
2024-05-20 17:30:56 | 29,550 0 |
29,550 | Form 4 |
| 11 | Peterson Kristine Director |
2024-04-23 16:06:26 | 28,587 0 |
28,587 | Form 4 |
| 12 | Jallal Bahija Director |
2024-01-29 16:15:57 | 17,884 0 |
17,884 | Form 4 |
| 13 | Nolet Chris Director |
2024-01-29 16:16:13 | 17,884 0 |
17,884 | Form 4 |